Foundayo (orforglipron) is an FDA-approved, once-daily oral GLP-1 receptor agonist pill developed by Eli Lilly for chronic weight management in adults with obesity or overweight.
Key Details
- How it works: It is a small-molecule, non-peptide pill that slows digestion and reduces appetite.
- Convenience: Unlike other oral GLP-1 options, it has no fasting, food, or water timing rules and can be taken at any time of day.
- Dosage: Treatment starts at a low dose of 0.8 mg daily and increases gradually every 30 days (moving through 2.5 mg, 5.5 mg, and up to a maximum of 17.2 mg) to minimize stomach side effects.
- Effectiveness: Clinical trials showed an average weight loss of about 11% to 12.4% at the highest dose over roughly 72 weeks.
- Side effects: Common issues include nausea, vomiting, diarrhea, and constipation. It also carries a warning regarding thyroid tumors seen in animal
-
- Cost: Cash prices can range from $149 to $299 per month depending on the dosage tier before insurance or savings cards like those on GoodRx. Prescriptions can be accessed through platforms like LillyDirect.
If you’re considering this medication, tell me:-
- Are you looking to manage weight loss or type 2 diabetes?
- Have you tried other GLP-1 medications (like Wegovy or Zepbound) before?
I can help you understand how it compares or what next steps to discuss with your doctor.



Reviews
There are no reviews yet.